BCL2 and nasopharyngeal carcinoma: Base on the IPA data, BCL2 could also be predicted to be the diagnostic marker of NPC as TP53, while it acted significantly in molecular mechanisms of cancer and functioned through apoptosis signaling (Fig. 3d).